Research Article
Left Ventricular Recovery after Transapical Transcatheter Aortic Valve Implantation Compared with Conventional Aortic Valve Replacement in Patients with Aortic Regurgitation and Reduced Ejection Fraction
Table 3
The effect of surgical strategy (TA-TAVI of C-AVR) on LVEF, LVEDD, and NYHA class using GEE models.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TA-TAVI, transapical transcatheter aortic valve implantation; C-AVR, conventional aortic valve replacement; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic dimension; NYHA, New York Heart Association; GEE, generalized estimating equations; CI, confidence interval. aBaseline covariates in the final adjusted GEE model: age, sex, body mass index, smoking history, diabetes, hypertension, peripheral vascular disease, NYHA class, atrial fibrillation, renal insufficiency, dialysis, cancer history, stroke history, coronary artery disease, prior myocardial infarction, liver dysfunction, prior cardiac surgery, LVEDD, bicuspid aortic valve, and additive EuroScore. bBaseline covariates in the final adjusted GEE model: age, sex, body mass index, smoking history, diabetes, hypertension, peripheral vascular disease, NYHA class, atrial fibrillation, renal insufficiency, dialysis, cancer history, stroke history, coronary artery disease, prior myocardial infarction, liver dysfunction, prior cardiac surgery, LVEF, bicuspid aortic valve, and additive Euroscore. cBaseline covariates in the final adjusted GEE model: age, sex, body mass index, smoking history, diabetes, hypertension, peripheral vascular disease, atrial fibrillation, renal insufficiency, dialysis, cancer history, stroke history, coronary artery disease, prior myocardial infarction, liver dysfunction, prior cardiac surgery, LVEF, LVEDD, bicuspid aortic valve, and additive Euroscore. |